The Association for Research in Vision and Ophthalmology (ARVO) is at the forefront of advancing global research aimed at unraveling the complexities of the visual system and combatting its disorders. From May 5th to May 9th, visionaries and experts congregated in Seattle, Washington, for the ARVO 2024 Annual Meeting, a pivotal event showcasing the latest breakthroughs and insights in the field.
Diving into the Presentations
The ARVO 2024 Annual Meeting featured a myriad of presentations and posters, each shedding light on critical aspects of vision research. Notably, several distinguished speakers represented Washington University Ophthalmology with their presentations:
- Dysregulated metabolism and inflammation in retinal disease presented by Rajendra S Apte, MD, PhD
- Racial Disparities of Nrf2 Expressions in Healthy Donor and Glaucomatous Human Trabecular Meshwork presented by Carla J Siegfried, MD
- Safety and Efficacy of Crizanlizumab in the Fatal Autosomal Dominant Familial Disease Retinal Vasculopathy with Cerebral Leukoencephalopathy presented by Wilson X. Wang
- Indispensable role of potassium channel KCNJ13 in the functional maintenance of RPE and photoreceptors presented by Chi Sun, PhD
- A genome-wide in vivo CRISPR-screen identifies neuroprotective targets in retinal degeneration presented by Ning Shen, PhD
- Genotype-Phenotype Associations for Cone-Rod Homeobox-linked Retinopathies presented by Isabella Gomes
- Ocular Hypertension Treatment Study: 20 yr quality of life (QoL) outcomes presented by Mae O Gordon, PhD
- How to minimize bias? presented by Mae O Gordon, PhD
- Overview of concept of power calculations for RCTs by Mae O Gordon, PhD
- Cellular homeostasis and resilience to degeneration in retinal ganglion cells in vivo presented by Philip Williams, PhD
- Method for Quantitative Evaluation of Posterior Vitreous Adhesion in Ex Vivo Porcine Eyes presented by Tara Suresh
- Novel Decellularization and Cryopreservation of Corneal Stroma for Lamellar Keratoplasty presented by Ying Liu
- Aberrant DNA cooperative binding underlies defective photoreceptor differentiation in mouse models of dominant CRX diseases presented by Yiqiao Zheng
- Inhibition and arbor morphology shape dendritic integration and feature selectivity in the retina presented by Chin I Lin
- Simultaneous Assessment of Vascular Responses and Oxygen Saturation Changes to Hypercapnia in Diabetic Mouse Retinas Using Dual-Color Optical Coherence Tomography presented by Chao Ren
- Pediatric Ocular Surface Inflammatory Diseases (POSID): Clinical Feature and Practice Patterns presented by Tanya Boghosian
Pre-ARVO 2024
At a pre-ARVO 2024 symposium, a joint effort by the National Eye Institute and Research to Prevent Blindness, aimed at mentoring early-career vision scientists, Dr. Rajendra Apte, MD, PhD, shared enlightening anecdotes and lessons from his professional journey.
The ARVO 2024 Annual Meeting was not only a platform for collaboration, innovation, and discovery but also a testament to the expertise and dedication of our DOVS family at Washington University in St. Louis. With each presentation, poster, and educational session, our colleagues gained valuable insights that will undoubtedly propel the field forward in understanding, preventing, treating, and curing visual disorders worldwide. As we reflect on the highlights of this event, we anticipate the transformative impact these breakthroughs will have on improving vision health for generations to come.